NCT06549686View on ClinicalTrials.gov

A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee

PHASE3RecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

October 20, 2023

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2031

Conditions
Osteoarthritis of the Knee
Interventions
BIOLOGICAL

CLS2901C (human [allogeneic] chondrocyte sheets)

CLS2901C (human \[allogeneic\] chondrocyte sheets)

Trial Locations (5)

243-0433

RECRUITING

Ebina General Hospital/Ebina Medical Plaza, Ebina

259-1193

RECRUITING

Tokai University Hospital, Isehara

230-0062

RECRUITING

Yokohama Sekishinkai Hospital, Yokohama

232-0024

RECRUITING

Yokohama City University Medical Center, Yokohama

113-8431

RECRUITING

Juntendo University Hospital, Bunkyō-Ku

Sponsors

Lead Sponsor

CellSeed Inc.
All Listed Sponsors
lead

CellSeed Inc.

INDUSTRY